Sanofi India Limited — Others, 16-07-2025: Appointment

Sanofi India's board has approved strategic changes. Rachid Ayari, current CFO, is appointed Interim Managing Director for six months or until a permanent MD is named, subject to shareholder approval. Aniket Raje joins as Head of Regulatory Affairs. The company entered an exclusive 5-year distribution agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, Amaryl® and Cetapin®. Sanofi will continue manufacturing, leveraging Emcure's network to expand market reach. This partnership aims to broaden access to key diabetes treatments across India, enhancing business impact.